Appointments at Protalix, Pevion, NeoStem and ProStraken – People on the move

By Nick Taylor

- Last updated on GMT

Related tags Executive vice president Chief operating officer Management occupations Vice president

in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Protalix, Pevion, NeoStem and ProStraken.

Protalix BioTherapeutics ​has appointed Tzvi Palash ​as chief operating officer. In this newly created role Palash will oversee manufacturing. Palash has more than 25 years of experience working at companies including ColBar LifeScience, CTS, Teva and Interpharm Laboratories.

Marc Tessier-Lavigne ​is leaving Genentech​ to become president of the Rockefeller University​. Tessier-Lavigne joined Genentech in 2003 and was promoted to executive vice president (EVP) for research and chief scientific officer in 2009.

Univar ​has appointed Steve Block ​as VP and president of​.

Evert Kueppers ​has been named as CEO of Pevion Biotech​, succeeding Thomas Stauffer​. Kueppers has previously worked at Pieris AG, IDEA AG, BASF Pharma and AT Kearney.

Intellect Neurosciences ​has hired Giora Feuerstein ​as a consultant. Feuerstein is the former head of discovery translational medicine at Wyeth and Pfizer.

Wilson Totten ​has resigned as CEO and as a director of ProStraken​. Peter Allen ​has been appointed as acting CEO. Totten resigned after news of regulatory delays and that closure of a contractor’s factory will impact profits.

Curemark ​has promoted James Szigethy ​to the position of director of new product development. Szigethy joined Curemark in 2007 having previously worked at Wal-Mart.

Craig Eagle ​has been elected to the board of directors at Regenicin​. Eagle is VP of strategic alliances and partnerships for the oncology business unit at Pfizer.

NeoStem ​has named Ian Zhang ​as president and managing director of its Chinese operations. Zhang is the former head of Asia Pacific integration at Life Technologies and has also worked at Invitrogen.

Related topics Markets & Regulations

Related news

Show more